Loading...
OTCM
ETBI
Market cap6mUSD
May 28, Last price  
0.00USD
Name

Eastgate Biotech Corp

Chart & Performance

D1W1MN
OTCM:ETBI chart
P/E
P/S
61.89
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
100k
-26.73%
000000132,0250157,379136,12599,735
Net income
-4m
L+136.63%
-23,649-24,354-29,920-622,820-1,720,316-4,907,686-4,281,310-2,977,471-3,719,462-1,497,815-3,544,249
CFO
114k
P
0000-407,675-1,243,510-568,444-389,478-1,395,854-258,164113,757

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
IPO date
Jan 16, 2014
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT